Vascular Graft Market by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral Vascular Repair), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End Users (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022

人工血管の世界市場予測(~2022年)

◆タイトル:Vascular Graft Market by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral Vascular Repair), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End Users (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022
◆商品コード:MAM-MD-5928
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年1月24日
◆ページ数:114
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、人工血管の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、セグメント別分析、地域別分析、人工血管の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Global vascular grafts market projected to grow at a CAGR of 7.3% during the forecast period”The vascular grafts market is expected to reach USD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a CAGR of 7.3%. The major factors driving the growth of this market are the high burden of abdominal aneurysms, increasing geriatric population, and increasing prevalence of smoking & other risk factors that promote aneurysms.
“The polyester segment is expected to grow at the highest growth rate during the forecast period”
On the basis of raw material, the vascular grafts market is segmented into ePTFE grafts, polyester grafts, polyurethane grafts, and biosynthetic grafts. Polyester grafts are expected to grow at the highest CAGR during the forecast period. The high growth rate of the segment can be attributed to the fact that most newly launched vascular grafts are made of polyester and because the advantages it offers such as high patency, high porousness, and reduced post-surgery side effects.
“The endovascular aneurysm repair segment is estimated to grow at the highest CAGR during the forecast period”
On the basis of indication, the vascular grafts market is classified into endovascular aneurysm repair or EVAR, hemodialysis access, and peripheral vascular aneurysm. The endovascular aneurysm repair segment is estimated to grow at the highest CAGR during the analysis period. The growth of this segment is mainly driven by the rising adoption of endovascular aneurysm repair surgical procedures, increasing preference for minimally invasive surgical procedures over open surgeries, and growing geriatric population.
“Asia Pacific is estimated to grow at the highest CAGR during the study period”
Geographically, the vascular grafts market is dominated by North America, followed by Europe in 2017, however, Asia Pacific is estimated to grow at the fastest rate during the forecast period. Growth in the APAC region can be attributed to the rising prevalence of chronic kidney disease, healthcare reforms, government initiatives and investments, and rapid growth in geriatric population. Emerging markets in the region, such as Australia, Singapore, Japan, and China also offer numerous growth opportunities for players operating in the vascular grafts.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Tier 1 – 60% and Tier 2 – 40%
• By Designation – C level – 62%, Director level – 21%, Others – 17%
• By Region – North America – 50%, Europe – 20%, Asia– 30%

The key players operating in this market are B. Braun (Germany), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US).
Research Coverage:
The report analyses the vascular grafts market by indication, raw material, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. This report also includes market research data, current market size, and forecast of the future trends that will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.
Key benefits of buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the vascular grafts market
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the vascular grafts market.
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the vascular grafts market.
• Market Development: Comprehensive information about emerging markets. This report analyses the market for various vascular grafts products across geographies.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vascular grafts market.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 DEFINITION 11
1.3 STUDY SCOPE 12
1.3.1 MARKETS COVERED 12
1.4 YEARS CONSIDERED FOR THE STUDY 13
1.5 CURRENCY 13
1.6 LIMITATIONS 13
1.7 STAKEHOLDERS 13
2 RESEARCH METHODOLOGY 14
2.1 RESEARCH DATA 14
2.1.1 SECONDARY DATA 15
2.1.1.1 Secondary sources 15
2.1.2 PRIMARY DATA 16
2.1.2.1 Key data from primary sources 17
2.2 MARKET SIZE ESTIMATION 17
2.2.1 BOTTOM-UP APPROACH 18
2.2.2 TOP-DOWN APPROACH 19
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 20
2.4 ASSUMPTIONS 21
3 EXECUTIVE SUMMARY 22
4 PREMIUM INSIGHTS 25
4.1 VASCULAR GRAFTS: MARKET OVERVIEW 25
4.2 VASCULAR GRAFTS MARKET, BY END USER 25
4.3 EUROPE: VASCULAR GRAFTS MARKET, BY RAW MATERIAL 26
4.4 GEOGRAPHIC SNAPSHOT OF THE VASCULAR GRAFTS MARKET 27
5 MARKET OVERVIEW 28
5.1 INTRODUCTION 28
5.2 MARKET DYNAMICS 28
5.2.1 DRIVERS 29
5.2.1.1 Growth in the aging population and the associated increase in the prevalence of aneurysm 29
5.2.1.2 Increasing prevalence of smoking 30
5.2.1.3 Increasing incidence of ESRD 30
5.2.1.4 Growing adoption of minimally invasive surgeries 31
5.2.2 RESTRAINT 31
5.2.2.1 Product failures and recalls 31
5.2.3 OPPORTUNITY 31
5.2.3.1 Emerging markets 31
5.2.4 TREND 32
5.2.4.1 Development of biosynthetic vascular grafts 32
6 VASCULAR GRAFTS MARKET, BY RAW MATERIAL 33
6.1 INTRODUCTION 34
6.2 POLYESTER GRAFTS 35
6.3 EPTFE GRAFTS 36
6.4 POLYURETHANE GRAFTS 37
6.5 BIOSYNTHETIC GRAFTS 38
7 GLOBAL VASCULAR GRAFTS MARKET, BY INDICATION 39
7.1 INTRODUCTION 40
7.2 ENDOVASCULAR ANEURYSM REPAIR 41
7.2.1 ABDOMINAL AORTIC ANEURYSMS REPAIR 42
7.2.2 THORACIC AORTIC ANEURYSM REPAIR 42
7.3 PERIPHERAL VASCULAR REPAIR 43
7.4 HEMODIALYSIS ACCESS 43
8 VASCULAR GRAFTS MARKET, BY END USER 45
8.1 INTRODUCTION 46
8.2 HOSPITALS 47
8.3 AMBULATORY SURGICAL CENTERS 48
9 VASCULAR GRAFTS MARKET, BY REGION 49
9.1 INTRODUCTION 50
9.2 NORTH AMERICA 51
9.2.1 US 53
9.2.2 CANADA 55
9.3 EUROPE 57
9.3.1 GERMANY 61
9.3.2 UK 62
9.3.3 FRANCE 64
9.3.4 ITALY 65
9.3.5 ROE 66
9.4 ASIA PACIFIC 68
9.4.1 CHINA 71
9.4.2 JAPAN 72
9.4.3 AUSTRALIA 74
9.4.4 INDIA 75
9.4.5 ROAPAC 76
9.5 REST OF THE WORLD 78
10 COMPETITIVE LANDSCAPE 81
10.1 OVERVIEW 81
10.2 MARKET SHARE ANALYSIS, 2016 82
10.3 COMPETITIVE SCENARIO 83
10.3.1 PRODUCT LAUNHCES 83
10.3.2 ACQUISITIONS 83
10.3.3 EXPANSIONS 84
10.3.4 AGREEMENTS 84
10.3.5 OTHER DEVELOPMENTS 84
11 COMPANY PROFILES 85
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 MEDTRONIC 85
11.2 TERUMO 88
11.3 C. R. BARD 90
11.4 B. BRAUN MELSUNGEN AG 92
11.5 CARDINAL HEALTH 94
11.6 ENDOLOGIX 96
11.7 LEMAITRE VASCULAR 98
11.8 COOK MEDICAL 100
11.9 MAQUET 102
11.10 GORE MEDICAL 103

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX 104
12.1 INSIGHTS FROM INDUSTRY EXPERTS 104
12.2 DISCUSSION GUIDE 105
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 107
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 109
12.5 AVAILABLE CUSTOMIZATIONS 111
12.6 RELATED REPORTS 111
12.7 AUTHOR DETAILS 112

LIST OF TABLES

TABLE 1 VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION) 34
TABLE 2 EXAMPLES OF POLYESTER GRAFTS OFFERED BY MARKET LEADERS 35
TABLE 3 POLYESTER VASCULAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION) 35
TABLE 4 SYNTHETIC POLYMERS: IN VIVO VASCULAR REGENERATION 36
TABLE 5 EXAMPLES OF EPTFE GRAFTS OFFERED BY MARKET LEADERS 36
TABLE 6 EPTFE VASCULAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION) 37
TABLE 7 EXAMPLES OF POLYURETHANE GRAFTS OFFERED BY MARKET LEADERS 37
TABLE 8 POLYURETHANE VASCULAR GRAFTS MARKET, BY REGION,
2015–2022 (USD MILLION) 37
TABLE 9 BIOSYNTHETIC VASCULAR GRAFTS MARKET, BY REGION,
2015–2022 (USD MILLION) 38
TABLE 10 VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 40
TABLE 11 EVAR GRAFTS MARKET, BY TYPE, 2015–2022 (USD MILLION) 41
TABLE 12 EVAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION) 41
TABLE 13 ABDOMINAL AORTIC ANEURYSM REPAIR MARKET, BY REGION,
2015–2022 (USD MILLION) 42
TABLE 14 THORACIC AORTIC ANEURYSM REPAIR MARKET, BY REGION,
2015–2022 (USD MILLION) 42
TABLE 15 PERIPHERAL VASCULAR REPAIR GRAFTS MARKET, BY REGION,
2015–2022 (USD MILLION) 43
TABLE 16 HEMODIALYSIS ACCESS GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 17 VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION) 46
TABLE 18 VASCULAR GRAFTS MARKET FOR HOSPITALS, BY REGION,
2015–2022 (USD MILLION) 47
TABLE 19 VASCULAR GRAFTS MARKET FOR AMBULATORY SURGICAL CENTERS,
BY REGION, 2015–2022 (USD MILLION) 48
TABLE 20 GLOBAL VASCULAR GRAFTS MARKET, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 21 NORTH AMERICA: VASCULAR GRAFTS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 52
TABLE 22 NORTH AMERICA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL,
2015–2022 (USD MILLION) 52
TABLE 23 NORTH AMERICA: VASCULAR GRAFTS MARKET, BY INDICATION,
2015–2022 (USD MILLION) 52
TABLE 24 NORTH AMERICA: VASCULAR GRAFTS MARKET, BY END USER,
2015–2022 (USD MILLION) 53
TABLE 25 INDICATIVE LIST OF RECENT EVENTS IN THE US 53
TABLE 26 US: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION) 54
TABLE 27 US : VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 54
TABLE 28 US: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION) 55
TABLE 29 CANADA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL,
2015–2022 (USD MILLION) 55
TABLE 30 CANADA: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 56
TABLE 31 CANADA: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION) 56
TABLE 32 GERIATRIC POPULATION IN EUROPEAN COUNTRIES (AS A PERCENTAGE OF THE TOTAL), 2005 VS. 2015 VS. 2025 58
TABLE 33 EUROPE: VASCULAR GRAFTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 60
TABLE 34 EUROPE: VASCULAR GRAFTS MARKET, BY RAW MATERIAL,
2015–2022 (USD MILLION) 60
TABLE 35 EUROPE: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 60
TABLE 36 EUROPE: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION) 61
TABLE 37 GERMANY: VASCULAR GRAFTS MARKET, BY RAW MATERIAL,
2015–2022 (USD MILLION) 61
TABLE 38 GERMANY: VASCULAR GRAFTS MARKET, BY INDICATION,
2015–2022 (USD MILLION) 62
TABLE 39 GERMANY: VASCULAR GRAFTS MARKET, BY END USER,
2015–2022 (USD MILLION) 62
TABLE 40 UK: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION) 63
TABLE 41 UK: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 63
TABLE 42 UK: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION) 63
TABLE 43 FRANCE: VASCULAR GRAFTS MARKET, BY RAW MATERIAL,
2015–2022 (USD MILLION) 64
TABLE 44 FRANCE: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 64
TABLE 45 FRANCE: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION) 65
TABLE 46 ITALY: VASCULAR GRAFTS MARKET, BY RAW MATERIAL,
2015–2022 (USD MILLION) 65
TABLE 47 ITALY: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 66
TABLE 48 ITALY: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION) 66
TABLE 49 ROE: VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2015–2022 (USD MILLION) 67
TABLE 50 ROE: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 67
TABLE 51 ROE: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION) 67
TABLE 52 PROPORTION OF OLDER PERSONS IN LABOUR FORCE AGED 65+, FOR SELECTED COUNTRIES (2016) 68
TABLE 53 ASIA PACIFIC: VASCULAR GRAFTS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 70
TABLE 54 ASIA PACIFIC: VASCULAR GRAFTS MARKET, BY RAW MATERIAL,
2015–2022 (USD MILLION) 70
TABLE 55 ASIA PACIFIC: VASCULAR GRAFTS MARKET, BY INDICATION,
2015–2022 (USD MILLION) 70
TABLE 56 ASIA PACIFIC: VASCULAR GRAFTS MARKET, BY END USER,
2015–2022 (USD MILLION) 71
TABLE 57 CHINA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL,
2015–2022 (USD MILLION) 71
TABLE 58 CHINA: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 72
TABLE 59 CHINA: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION) 72
TABLE 60 JAPAN: VASCULAR GRAFTS MARKET, BY RAW MATERIAL,
2015–2022 (USD MILLION) 73
TABLE 61 JAPAN: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 73
TABLE 62 JAPAN: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION) 73
TABLE 63 AUSTRALIA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL,
2015–2022 (USD MILLION) 74
TABLE 64 AUSTRALIA: VASCULAR GRAFTS MARKET, BY INDICATION,
2015–2022 (USD MILLION) 74
TABLE 65 AUSTRALIA: VASCULAR GRAFTS MARKET, BY END USER,
2015–2022 (USD MILLION) 75
TABLE 66 INDIA: VASCULAR GRAFTS MARKET, BY RAW MATERIAL,
2015–2022 (USD MILLION) 75
TABLE 67 INDIA: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 76
TABLE 68 INDIA: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION) 76
TABLE 69 ROAPAC: VASCULAR GRAFTS MARKET, BY RAW MATERIAL,
2015–2022 (USD MILLION) 77
TABLE 70 ROAPAC: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 77
TABLE 71 ROAPAC: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION) 77
TABLE 72 OBESITY PREVALENCE IN LATIN AMERICA, BY COUNTRY, 2014 78
TABLE 73 ROW: VASCULAR GRAFTS MARKET, BY RAW MATERIAL,
2015–2022 (USD MILLION) 80
TABLE 74 ROW: VASCULAR GRAFTS MARKET, BY INDICATION, 2015–2022 (USD MILLION) 80
TABLE 75 ROW: VASCULAR GRAFTS MARKET, BY END USER, 2015–2022 (USD MILLION) 80


LIST OF FIGURES

FIGURE 1 GLOBAL VASCULAR GRAFTS MARKET 12
FIGURE 2 RESEARCH DESIGN 14
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 16
FIGURE 4 DATA TRIANGULATION METHODOLOGY 20
FIGURE 5 VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2017 VS. 2022 (USD BILLION) 22
FIGURE 6 VASCULAR GRAFTS MARKET, BY INDICATION, 2017 VS. 2022 (USD BILLION) 23
FIGURE 7 VASCULAR GRAFTS MARKET, BY END USER 2017 VS. 2022 (USD BILLION) 23
FIGURE 8 VASCULAR GRAFTS MARKET, BY REGION, 2017 VS. 2022 (USD BILLION) 24
FIGURE 9 INCREASING GERIATRIC POPULATION AND HIGH PREVALENCE OF ANEURYSMS TO DRIVE THE MARKET 25
FIGURE 10 HOSPITALS TO DOMINATE THE VASCULAR GRAFTS MARKET DURING THE FORECAST PERIOD 25
FIGURE 11 POLYESTER GRAFTS TO DOMINATE THE EUROPEAN VASCULAR GRAFTS MARKET
IN 2017 26
FIGURE 12 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 27
FIGURE 13 VASCULAR GRAFTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS 28
FIGURE 14 GLOBAL GERIATRIC POPULATION (60 YEARS AND ABOVE), 2015 VS. 2030 (MILLION) 29
FIGURE 15 POLYESTER GRAFTS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 34
FIGURE 16 EVAR SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 40
FIGURE 17 HOSPITALS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 46
FIGURE 18 VASCULAR GRAFTS MARKET IN ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 50
FIGURE 19 NORTH AMERICA MARKET SNAPSHOT 51
FIGURE 20 EUROPE SNAPSHOT 59
FIGURE 21 ASIA PACIFIC MARKET SNAPSHOT 69
FIGURE 22 ROW VASCULAR GRAFTS MARKET SNAPSHOT 79
FIGURE 23 KEY DEVELOPMENTS ADOPTED BY THE TOP PLAYERS IN VASCULAR GRAFTS MARKET BETWEEN 2014 AND 2017 81
FIGURE 24 SHARES OF COMPANIES IN THE VASCULAR GRAFTS MARKET, 2016 82
FIGURE 25 MEDTRONIC: COMPANY SNAPSHOT 85
FIGURE 26 TERUMO: COMPANY SNAPSHOT 88
FIGURE 27 C. R. BARD: COMPANY SNAPSHOT 90
FIGURE 28 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT 92
FIGURE 29 CARDINAL HEALTH: COMPANY SNAPSHOT 94
FIGURE 30 ENDOLOGIX: COMPANY SNAPSHOT 96
FIGURE 31 LEMAITRE VASCULAR: COMPANY SNAPSHOT 98


【レポートのキーワード】

人工血管、血管グラフト

★調査レポート[人工血管の世界市場予測(~2022年)] ( Vascular Graft Market by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral Vascular Repair), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End Users (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022 / MAM-MD-5928) 販売に関する免責事項
[人工血管の世界市場予測(~2022年)] ( Vascular Graft Market by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral Vascular Repair), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End Users (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022 / MAM-MD-5928) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆